Thoroughbred Financial Services’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-972
| Closed | -$408K | – | 629 |
|
|
2025
Q1 | $408K | Sell |
972
-15
| -2% | -$6.3K | 0.03% | 464 |
|
|
2024
Q4 | $408K | Sell |
987
-16
| -2% | -$6.61K | 0.02% | 465 |
|
|
2024
Q3 | $506K | Sell |
1,003
-250
| -20% | -$126K | 0.03% | 392 |
|
|
2024
Q2 | $610K | Buy |
1,253
+853
| +213% | +$415K | 0.04% | 351 |
|
|
2024
Q1 | $215K | Sell |
400
-871
| -69% | -$468K | 0.02% | 433 |
|
|
2023
Q4 | $705K | Sell |
1,271
-6
| -0.5% | -$3.33K | 0.06% | 305 |
|
|
2023
Q3 | $558K | Buy |
1,277
+877
| +219% | +$383K | 0.05% | 305 |
|
|
2023
Q2 | $200K | Hold |
400
| – | – | 0.03% | 408 |
|
|
2023
Q1 | $200K | Buy |
+400
| New | +$200K | 0.03% | 393 |
|
|
2022
Q2 | – | Sell |
-455
| Closed | -$248K | – | 379 |
|
|
2022
Q1 | $248K | Sell |
455
-215
| -32% | -$117K | 0.04% | 338 |
|
|
2021
Q4 | $441K | Sell |
670
-70
| -9% | -$46.1K | 0.09% | 213 |
|
|
2021
Q3 | $460K | Buy |
740
+25
| +3% | +$15.5K | 0.11% | 184 |
|
|
2021
Q2 | $452K | Hold |
715
| – | – | 0.11% | 186 |
|
|
2021
Q1 | $349K | Buy |
715
+5
| +0.7% | +$2.44K | 0.1% | 199 |
|
|
2020
Q4 | $354K | Sell |
710
-225
| -24% | -$112K | 0.11% | 176 |
|
|
2020
Q3 | $367K | Hold |
935
| – | – | 0.14% | 154 |
|
|
2020
Q2 | $309K | Hold |
935
| – | – | 0.13% | 168 |
|
|
2020
Q1 | $226K | Hold |
935
| – | – | 0.08% | 218 |
|
|
2019
Q4 | $244K | Hold |
935
| – | – | 0.08% | 215 |
|
|
2019
Q3 | $254K | Hold |
935
| – | – | 0.1% | 200 |
|
|
2019
Q2 | $257K | Hold |
935
| – | – | 0.1% | 165 |
|
|
2019
Q1 | $209K | Buy |
+935
| New | +$209K | 0.09% | 219 |
|